Cargando…

Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection

BACKGROUND: Obesity is associated with increased risk for death in most infections but has not been studied as a risk factor for mortality in Clostridioides difficile infection (CDI). This study tested obesity as a risk factor for death in patients hospitalized with CDI. This was a three-center retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Malick, Alyyah, Wang, Ying, Axelrad, Jordan, Salmasian, Hojjat, Freedberg, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799984/
https://www.ncbi.nlm.nih.gov/pubmed/35093158
http://dx.doi.org/10.1186/s13099-022-00479-z
_version_ 1784642166537060352
author Malick, Alyyah
Wang, Ying
Axelrad, Jordan
Salmasian, Hojjat
Freedberg, Daniel
author_facet Malick, Alyyah
Wang, Ying
Axelrad, Jordan
Salmasian, Hojjat
Freedberg, Daniel
author_sort Malick, Alyyah
collection PubMed
description BACKGROUND: Obesity is associated with increased risk for death in most infections but has not been studied as a risk factor for mortality in Clostridioides difficile infection (CDI). This study tested obesity as a risk factor for death in patients hospitalized with CDI. This was a three-center retrospective study that included hospitalized adults with CDI at Columbia University Irving Medical Center, Brigham and Women’s Hospital, and NYU Langone from 2010 to 2018. Multivariate logistic regression was used to assess the relationship between obesity, measured by body mass index, and death from any cause within 30 days after the index CDI test. RESULTS: Data for 3851 patients were analyzed, including 373 (9.7%) who died within 30 days following a diagnosis of CDI. After adjusting for other factors, BMI was not associated with increased risk for death in any BMI category [adjusted OR (aOR) 0.96, 95% CI 0.69 to 1.34 for BMI > 30 vs BMI 20–30; aOR 1.02, 95% CI 0.53 to 1.87 for BMI > 40 vs BMI 20–30]. After stratifying into three groups by age, there were trends towards increased mortality with obesity in the middle-aged (56–75 vs ≤ 55 years old) yet decreased mortality with obesity in the old (> 75 vs ≤ 55) (p = NS for all). Advanced age and low albumin were the factors most strongly associated with death. CONCLUSIONS: We found no association between obesity and death among patients with CDI, in contrast to most other infections. Obesity is not likely to be useful for risk-stratifying hospitalized patients with CDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13099-022-00479-z.
format Online
Article
Text
id pubmed-8799984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87999842022-01-31 Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection Malick, Alyyah Wang, Ying Axelrad, Jordan Salmasian, Hojjat Freedberg, Daniel Gut Pathog Research BACKGROUND: Obesity is associated with increased risk for death in most infections but has not been studied as a risk factor for mortality in Clostridioides difficile infection (CDI). This study tested obesity as a risk factor for death in patients hospitalized with CDI. This was a three-center retrospective study that included hospitalized adults with CDI at Columbia University Irving Medical Center, Brigham and Women’s Hospital, and NYU Langone from 2010 to 2018. Multivariate logistic regression was used to assess the relationship between obesity, measured by body mass index, and death from any cause within 30 days after the index CDI test. RESULTS: Data for 3851 patients were analyzed, including 373 (9.7%) who died within 30 days following a diagnosis of CDI. After adjusting for other factors, BMI was not associated with increased risk for death in any BMI category [adjusted OR (aOR) 0.96, 95% CI 0.69 to 1.34 for BMI > 30 vs BMI 20–30; aOR 1.02, 95% CI 0.53 to 1.87 for BMI > 40 vs BMI 20–30]. After stratifying into three groups by age, there were trends towards increased mortality with obesity in the middle-aged (56–75 vs ≤ 55 years old) yet decreased mortality with obesity in the old (> 75 vs ≤ 55) (p = NS for all). Advanced age and low albumin were the factors most strongly associated with death. CONCLUSIONS: We found no association between obesity and death among patients with CDI, in contrast to most other infections. Obesity is not likely to be useful for risk-stratifying hospitalized patients with CDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13099-022-00479-z. BioMed Central 2022-01-29 /pmc/articles/PMC8799984/ /pubmed/35093158 http://dx.doi.org/10.1186/s13099-022-00479-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Malick, Alyyah
Wang, Ying
Axelrad, Jordan
Salmasian, Hojjat
Freedberg, Daniel
Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection
title Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection
title_full Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection
title_fullStr Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection
title_full_unstemmed Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection
title_short Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection
title_sort obesity is not associated with adverse outcomes among hospitalized patients with clostridioides difficile infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799984/
https://www.ncbi.nlm.nih.gov/pubmed/35093158
http://dx.doi.org/10.1186/s13099-022-00479-z
work_keys_str_mv AT malickalyyah obesityisnotassociatedwithadverseoutcomesamonghospitalizedpatientswithclostridioidesdifficileinfection
AT wangying obesityisnotassociatedwithadverseoutcomesamonghospitalizedpatientswithclostridioidesdifficileinfection
AT axelradjordan obesityisnotassociatedwithadverseoutcomesamonghospitalizedpatientswithclostridioidesdifficileinfection
AT salmasianhojjat obesityisnotassociatedwithadverseoutcomesamonghospitalizedpatientswithclostridioidesdifficileinfection
AT freedbergdaniel obesityisnotassociatedwithadverseoutcomesamonghospitalizedpatientswithclostridioidesdifficileinfection